Heart-Related Deaths More Likely During Day/Night Heatwaves
By Dennis Thompson HealthDay Reporter
MONDAY, April 7, 2025 -- More people die from heart problems during heatwaves where high temperatures stretch through both the day and night, a new study says.
Heatwaves that offer no relief at night -- known as compound heatwaves -- are much more deadly than soaring daytime temperatures alone, researchers reported April 1 in the Journal of the American College of Cardiology.
People are 86% more likely to die from a heart-related condition during a compound heatwave, compared to a 19% increased risk from daytime-only heatwaves and 16% from nighttime-only heatwaves, researchers said.
“Traditional heatwave definitions fail to capture the full scope of these risks,” senior researcher Renjie Chen, a professor at Fudan University School of Public Health in Shanghai, China, said in a news release.
For the study, researchers analyzed data for nearly 2.4 million heart disease deaths that occurred in mainland China from 2013 to 2019, comparing them to hourly temperatures.
Results showed that risk of heart-related death increases steadily during a compound heatwave, while risk tends to peak and then decline during daytime or nighttime heatwaves.
People were particularly more likely to die from sudden cardiac arrest, heart attack and heart failure during a compound heatwave, researchers found.
For example, compound heatwaves brought an 86% increased risk of death from sudden cardiac arrest, compared with a 37% increased risk from nighttime and 24% increased risk of daytime heatwaves.
Likewise, heart attack deaths were 88% more likely during a compound heatwave versus 16% during a nighttime and 13% during a daytime heatwave.
And heart failure deaths were 97% more likely in a compound heatwave, but just 24% more likely in either a daytime or nighttime heatwave.
These results show that more effort needs to be put on protecting people from continual heat, such as providing cooling shelters in cities and improving climate control in homes, researchers said.
“Given the increasing frequency and intensity of compound heatwaves due to climate change, our findings highlight the need for disease-specific prevention strategies and revised public health guidelines to better protect at-risk populations,” Chen said.
Researchers next plan to project how many people are likely to die from heatwave-related heart problems under different climate change scenarios.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-04-08 00:00
Read more

- New Bill Targets Harmful Ingredients in California School Food
- Tuberculosis on the Rise Again in the United States
- CagriSema Demonstrates Superior Weight Loss in Adults with Obesity or Overweight and Type 2 Diabetes in the REDEFINE 2 Trial
- Capricor Therapeutics Announces FDA Acceptance and Priority Review of its Biologics License Application for Deramiocel to Treat Duchenne Muscular Dystrophy
- Alnylam Announces FDA Approval of Amvuttra (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hospitalizations and Urgent Heart Failure Visits in Adults with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM)
- ACC: Microplastic Exposure Tied to Chronic Disease Prevalence
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions